Bvlgari global CEO Jean-Jean-Christophe Babin. Photo: Bvlgari


Bvlgari, the Italian luxury brand, announced this month that it will be helping to support research into covid-19 and vaccine development at Rockefeller University in New York City.

In September, Bulgari announced the formation of the Bvlgari Virus Free Fund, which is a financial program created to support various institutions researching covid-19 vaccines.

Currently, the U.S. branch of the luxury accessories house is taking an additional step in the fight against virus by launching an initiative that will provide financial research aid to women scientists, postdoctoral scholars and graduate students through the Bvlgari Women and Science Fellowship.

Bvlgari has also opened a clinical fund to help finance the development and clinical testing of new therapies, drugs and vaccines to combat the pandemic.

Since the onset of the coronavirus pandemic in March of last year, the haute couture brand has taken a proactive stance in supporting health efforts worldwide, providing sanitizing gel and other personal protective equipment (PPE) to hospitals and clinics around the globe, and helping to fund Oxford University’s development of its vaccine with the British-Swedish multinational pharmaceutical AstraZeneca.

“Bulgari is proud to announce a further step in its growing commitment to sustainability and corporate social responsibility,” said Bvlgari global CEO Jean-Jean-Christophe Babin, adding that both the company and Rockefeller University are “pursuing the common goal to achieve remission and cure of the covid-19 virus, while supporting the brilliant women scientists working on covid research.”

…Jan. 13, 2021

Leave a Reply